![Richard Gaynor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Gaynor
Director/Board Member at
ALKERMES PLC
Net worth: 3 M $ as of 29/06/2026
Profile
Richard Brian Gaynor is currently Director at Alkermes, Inc. since 2019, Director at The Damon Runyon Cancer Research Foundation, Independent Director at Alkermes Plc since 2019, and Independent Director at Zai Lab Ltd. since 2021.
Former positions include Independent Director at Infinity Pharmaceuticals, Inc. from 2020 to 2024, President-Research & Development at BioNTech US, Inc. from 2016 to 2020, Vice President-Clinical Development at Eli Lilly & Co. from 2002 to 2015, Senior VP-Clinical Development & Medical Affairs at Lilly Oncology, Director-Simmons Cancer Center at The University of Texas Southwestern Medical Center from 1998 to 2002, and Director & Chief-Hematology at Harold C Simmons Comprehensive Cancer Center.
Education includes undergraduate studies at Texas Tech University and a doctorate from The University of Texas Southwestern Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/05/2026 | 35,751 ( 0.02% ) | 2 M $ | 29/06/2026 | |
ZAI LAB LTD. 0.07% | 30/06/2026 | 807,370 ( 0.07% ) | 1 M $ | 29/06/2026 |
Richard Gaynor active positions
| Companies | Position | Start |
|---|---|---|
| ALKERMES PLC | Director/Board Member | 11/09/2019 |
| ZAI LAB LIMITED | Director/Board Member | 18/11/2021 |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Director/Board Member | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Director/Board Member | 31/08/2019 |
Former positions of Richard Gaynor
| Companies | Position | End |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 29/02/2024 |
| NEON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/04/2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 30/09/2016 |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/07/2002 |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Training of Richard Gaynor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Harold C Simmons Comprehensive Cancer Center |
- Stock Market
- Insiders
- Richard Gaynor
